TELCON RF PHARMACEUTICAL. Inc. (KOSDAQ:200230)

South Korea · Delayed Price · Currency is KRW

2,265.00

-130.00 (-5.43%)

Oct 8, 2026, 3:30 PM KST

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
RF Business Division	9.98B	12.77B	11.81B	12.40B	26.43B
Pharmaceutical/Bio Business Division	34.72B	26.87B	25.89B	16.49B	15.23B
Elimination of Internal Transactions, Etc.	-1.54B	-1.78B	-1.40B	-1.06B	-3.82B
Total	43.16B	37.87B	36.31B	27.83B	37.84B

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
South Korea	36.05B	31.68B	30.21B	18.64B	20.00B
Asia	3.54B	2.56B	2.86B	6.00B	14.88B
North America	3.58B	3.63B	3.23B	3.19B	2.97B
Total	43.16B	37.87B	36.31B	27.83B	37.84B